News About: Pharm. Industry


Pharmaceutical pharmas in progress of acquiring ISO37001

Pharmaceutical companies are accelerating for ethical management. They are clearly carving ‘ISO37001(Anti-Bribery Management Systems),’ which is a great way to show a strong will to eradicate illegal rebates, into the...

THAAD crisis soon to be resolved in cosmetic industry

Even though there was a high expectation for the congestion created by the THAAD issue to be resolved this year, the downtrend continued even in the 1st quarter. A number of Korean cosmetic companies received report c...

Korean pharmas developed 9 products of 8 types biosimilars like Remsima

It was reported 9 biologic products of 8 types were developed by Korean pharmaceutical companies, such as Celltrion with the rheumatoid arthritis therapy ‘Remsima Inj.’ According to the Ministry of Food and Drug Safe...

How listed pharmaceutical companies spent for R&D expenses?

In the 1st quarter of this year, KOSPI listed pharmaceutical companies have spent twice more into R&D than what KOSDAQ listed pharmaceutical companies spent. Yakup Shinmoon(www.yakup.com) analyzed R&D expenses that 3...

How listed pharmas did with overseas sales and exports?

This 1st quarter, both of KOSPI and KOSDAQ listed pharmaceutical companies has a decrease in overseas sales & exports on average compared to the same quarter of the last year. Yakup Shinmoon(www.yakup.com) analyzed o...

Pharmaceutical Product Approval Renewal leads pharmas to reshuffle their products

The pharmaceutical product approval & registration renewal system starting last July was analyzed to lead the pharmaceutical industry to reshuffle their pharmaceutical products. This is because 1 of 5 subjects to the...

Samsung Bioepis reveals clinical trial results of SB3 at ASCO in U.S.

Samsung Bioepis(CEO/President Han-Seung Ko) revealed the 1-year clinical trial result of SB3(Herceptin biosimilar, generic name: trastuzumab, European name: Ontruzant, Korean name: Samfenet), a breast cancer therapy. ...

LG Chem targets Japan with ‘Etanercept’ referencing Enbrel

LG Chem will aggressively target the Japanese ‘Etanercept’ market worth of KRW 400 billion. When it comes to this news on the 30th, LG Chem completed registering health insurance benefit price of ‘Etanercept BS, refe...

Hanall Biopharma & Daewoong Pharmaceutical announce U.S. Phase II clinical trial of new dry eye therapy

On the 29th, Hanall Biopharma and Daewoong Pharmaceutical announced their U.S. Phase II clinical trial(a.k.a. Topline) result of the dry eye treatment biosimilar HL036 that they are jointly developing. The Phase II cl...

How listed pharmas did with sales?

In the 1st quarter of this year, both KOSPI and KOSDAQ listed pharmaceutical companies had an increase of approximately 6% in sales compared to the same quarter of the last year. Yakup Shinmoon(www.yakup.com) analyze...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.